MS Contin

MS Contin is a brand name of morphine, approved by the FDA in the following formulation(s):

MS CONTIN (morphine sulfate - tablet, extended release; oral)

• 
  Manufacturer: PURDUE PHARMA LP
  
  Approval date: May 29, 1987
  
  Strength(s): 30MG ^[AB]


• 
  Manufacturer: PURDUE PHARMA LP
  
  Approval date: April 8, 1988
  
  Strength(s): 60MG ^[AB]


• 
  Manufacturer: PURDUE PHARMA LP
  
  Approval date: September 12, 1989
  
  Strength(s): 15MG ^[AB]


• 
  Manufacturer: PURDUE PHARMA LP
  
  Approval date: January 16, 1990
  
  Strength(s): 100MG ^[RLD][AB]


• 
  Manufacturer: PURDUE PHARMA LP
  
  Approval date: November 8, 1993
  
  Strength(s): 200MG ^[AB]

Has a generic version of MS Contin been approved?

Yes. The following products are equivalent to MS Contin:

morphine sulfate tablet, extended release; oral

• 
  Manufacturer: CLONMEL HLTHCARE
  
  Approval date: January 28, 2000
  
  Strength(s): 15MG ^[AB]


• 
  Manufacturer: ENDO PHARMS
  
  Approval date: October 28, 1998
  
  Strength(s): 15MG ^[AB], 30MG ^[AB], 60MG ^[AB]


• 
  Manufacturer: ENDO PHARMS
  
  Approval date: September 15, 2000
  
  Strength(s): 100MG ^[AB], 200MG ^[AB]


• 
  Manufacturer: MALLINCKRODT
  
  Approval date: July 3, 2003
  
  Strength(s): 100MG ^[AB], 200MG ^[AB]


• 
  Manufacturer: MALLINCKRODT
  
  Approval date: July 31, 2003
  
  Strength(s): 15MG ^[AB], 30MG ^[AB], 60MG ^[AB]


• 
  Manufacturer: MYLAN PHARMS INC
  
  Approval date: October 18, 2011
  
  Strength(s): 100MG ^[AB], 15MG ^[AB], 200MG ^[AB], 30MG ^[AB], 60MG ^[AB]


• 
  Manufacturer: NESHER PHARMS
  
  Approval date: May 19, 2004
  
  Strength(s): 15MG ^[AB], 60MG ^[AB]


• 
  Manufacturer: NESHER PHARMS
  
  Approval date: December 23, 2005
  
  Strength(s): 30MG ^[AB]


• 
  Manufacturer: NESHER PHARMS
  
  Approval date: September 27, 2007
  
  Strength(s): 100MG ^[AB], 200MG ^[AB]


• 
  Manufacturer: RHODES PHARMS
  
  Approval date: July 2, 1998
  
  Strength(s): 100MG ^[AB], 200MG ^[AB]


• 
  Manufacturer: RHODES PHARMS
  
  Approval date: July 7, 1998
  
  Strength(s): 15MG ^[AB], 30MG ^[AB], 60MG ^[AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of MS Contin. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with MS Contin.

See also...

• MS Contin Consumer Information (Drugs.com)
• MS Contin Sustained-Release Tablets Consumer Information (Wolters Kluwer)
• MS Contin Consumer Information (Cerner Multum)
• MS Contin Advanced Consumer Information (Micromedex)
• Morphine Consumer Information (Drugs.com)
• Morphine Concentrate Consumer Information (Wolters Kluwer)
• Morphine Extended-Release Capsules Consumer Information (Wolters Kluwer)
• Morphine Immediate-Release Consumer Information (Wolters Kluwer)
• Morphine Immediate-Release Tablets Consumer Information (Wolters Kluwer)
• Morphine Soluble Tablets Consumer Information (Wolters Kluwer)
• Morphine Solution Consumer Information (Wolters Kluwer)
• Morphine Suppositories Consumer Information (Wolters Kluwer)
• Morphine Sustained-Release Tablets Consumer Information (Wolters Kluwer)
• Morphine IR Consumer Information (Cerner Multum)
• Morphine Consumer Information (Cerner Multum)
• DepoDur Advanced Consumer Information (Micromedex)
• Morphine Advanced Consumer Information (Micromedex)
• Morphine Epidural Advanced Consumer Information (Micromedex)
• Morphine Injection Advanced Consumer Information (Micromedex)
• Morphine Sulfate AHFS DI Monographs (ASHP)